Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101

Cancer Statistics, 2001

Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. J. (2001) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,281

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337

Delineation of prognostic biomarkers in prostate cancer

Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R. B., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,675

Is a p53-Regulated Inhibitor of G2/M Progression

Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251

Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions

Hruban, R. H., Adsay, N. V., Albores–Saavedra, J., Compton, C., Garrett, E. S., Goodman, S. N., Kern, S. E., Klimstra, D. S., Klöppel, G., Longnecker, D. S., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200105000-00003 · Cited by 1,126

Specific protection against breast cancers by cyclin D1 ablation

Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934

Progression model for pancreatic cancer.

Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 872

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.

Chang, K., & Pastan, I. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.136 · Cited by 747

Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer

Reiter, R. E., Gu, Z., Watabe, T., THOMAS, G. V., Szigeti, K., Davis, E., Wahl, M. I., Nisitani, S., Yamashiro, J. M., Beau, M. M. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1735 · Cited by 675

Pdx1 Expression in Pancreatic Precursor Lesions and Neoplasms

Park, J. Y., Hong, S., Klimstra, D. S., Goggins, M., Maitra, A., & Hruban, R. H. (2011) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e318206d958 · Cited by 64

Neoplasms of the Exocrine Pancreas

Wolff, R. A., Crane, C. H., Li, D., Evans, D. B., Maitra, A., & Tsai, S. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm094 · Cited by 64

KRAS: the Achilles’ heel of pancreas cancer biology

Drizyte‐Miller, K., Talabi, T., Somasundaram, A., Cox, A. D., & Der, C. J. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191939 · Cited by 70

Mutant p53-Expressing Cells Undergo Necroptosis via Cell Competition with the Neighboring Normal Epithelial Cells

Watanabe, H., Ishibashi, K., Mano, H., Kitamoto, S., Sato, N., Hoshiba, K., Mugihiko, K., Matsuzawa, F., Takeuchi, Y., Shirai, T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.081 · Cited by 64

In vivo disruption of TGF-β signaling by Smad7 leads to premalignant ductal lesions in the pancreas

Kuang, C., Xiao, Y., Liu, X., Stringfield, T. M., Zhang, S., Wang, Z., & Chen, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508977103 · Cited by 63

Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade

Yamaguchi, H., Inoue, T., Eguchi, T., Miyasaka, Y., Ohuchida, K., Mizumoto, K., Yamada, T., Yamaguchi, K., Tanaka, M., & Tsuneyoshi, M. (2007) · Modern Pathology · doi:10.1038/modpathol.3800763 · Cited by 61

Ductal Neoplasia of the Pancreas: Nosologic, Clinicopathologic, and Biologic Aspects

Adsay, V. N., Baştürk, O., Cheng, J. D., & Andea, A. A. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.04.001 · Cited by 60

The usefulness of S100P, mesothelin, fascin, prostate stem cell antigen, and 14‐3‐3 sigma in diagnosing pancreatic adenocarcinoma in cytological specimens obtained by endoscopic ultrasound guided fine‐needle aspiration

Dim, D. C., Jiang, F., Qiu, Q., Li, T., Darwin, P. E., Rodgers, W. H., & Peng, H. Q. (2011) · Diagnostic Cytopathology · doi:10.1002/dc.21684 · Cited by 59

Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma

Zhang, J., Zhu, Y., Zhu, Y., Wu, J., Liang, W., Zhu, R., Xu, Z., Du, Q., & Miao, Y. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0770-x · Cited by 58

Molecular Genetics of Pancreatic Ductal Adenocarcinomas and Recent Implications for Translational Efforts

Feldmann, G., & Maitra, A. (2008) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070115 · Cited by 57

Pancreatic Intraepithelial Neoplasia and Pancreatic Tumorigenesis: Of Mice and Men

Ottenhof, N. A., Milne, A. N., Morsink, F. H. M., Drillenburg, P., ten Kate, F. J. W., Maitra, A., & Offerhaus, G. J. A. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.3.375 · Cited by 57

Multifaceted role for p53 in pancreatic cancer suppression

Mello, S. S., Flowers, B. M., Mazur, P. K., Lee, J. J., Müller, F., Denny, S. K., Ferreira, S., Hanson, K., Kim, S. K., Greenleaf, W. J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211937120 · Cited by 55

S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells

Barry, S., Chelala, C., Lines, K. E., Sunamura, M., Wang, A., Marelli‐Berg, F. M., Brennan, C. H., Lemoine, N. R., & Crnogorac‐Jurcevic, T. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9532-y · Cited by 55

Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs)

Koorstra, J.-B. M., Feldmann, G., Habbe, N., & Maitra, A. (2008) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-008-0282-x · Cited by 54

Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations

Ozaki, T., Yu, M., Yin, D., Sun, D., Zhu, Y., Bu, Y., & Sang, M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4217-9 · Cited by 57

Pancreatic Cancer and Its Microenvironment—Recent Advances and Current Controversies

Stopa, K. B., Kusiak, A. A., Szopa, M. D., Ferdek, P. E., & Jakubowska, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093218 · Cited by 55

Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer

Ohuchida, K., Mizumoto, K., Yamada, D., Fujii, K., Ishikawa, N., Konomi, H., Nagai, E., Yamaguchi, K., Tsuneyoshi, M., & Tanaka, M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21317 · Cited by 54

A genetic roadmap of pancreatic cancer: still evolving

Notta, F., Hahn, S. A., & Real, F. X. (2017) · Gut · doi:10.1136/gutjnl-2016-313317 · Cited by 54

Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas

O'Neal, R. L., Nam, K. T., LaFleur, B., Barlow, B., Nozaki, K., Lee, H., Kim, W. H., Yang, H., Shi, C., Maitra, A., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.07.017 · Cited by 53

Precursor Lesions of Pancreatic Cancer

Kim, J. Y., & Hong, S. (2018) · Oncology Research and Treatment · doi:10.1159/000493554 · Cited by 52

Application of a Global Proteomic Approach to Archival Precursor Lesions: Deleted in Malignant Brain Tumors 1 and Tissue Transglutaminase 2 Are Upregulated in Pancreatic Cancer Precursors

Cheung, W. L., Darfler, M. M., Alvarez, H., Hood, B. L., Conrads, T. P., Habbe, N., Krizman, D. B., Mollenhauer, J., Feldmann, G., & Maitra, A. (2008) · Pancreatology · doi:10.1159/000161012 · Cited by 52

Current understanding of precursors to pancreatic cancer

Takaori, K. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1165-6 · Cited by 51

Characterization of human mesothelin transcripts in ovarian and pancreatic cancer

Muminova, Z., Strong, T. V., & Shaw, D. R. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-19 · Cited by 51

Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies

Linehan, A., O’Reilly, M., McDermott, R., & O'Kane, G. M. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1369136 · Cited by 57

The Expression Pattern of PDX-1, SHH, Patched and Gli-1 Is Associated with Pathological and Clinical Features in Human Pancreatic Cancer

Quint, K., Stintzing, S., Alinger, B., Hauser‐Kronberger, C., Dietze, O., Gahr, S., Hahn, E. G., Ocker, M., & Neureiter, D. (2008) · Pancreatology · doi:10.1159/000178882 · Cited by 49

Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas

Pittman, M. E., Rao, R. A., & Hruban, R. H. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0426-ra · Cited by 49

Nanoparticulate delivery of diphtheria toxin DNA effectively kills mesothelin expressing pancreatic cancer cells

Showalter, S. L., Huang, Y.-H., Witkiewicz, A. K., Costantino, C. L., Yeo, C. J., Green, J. J., Langer, R., Anderson, D. G., Sawicki, J. A., & Brody, J. R. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.10.6562 · Cited by 48

Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer

Guo, J., Xie, K., & Zheng, S. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.14995 · Cited by 47

Cancerization of the Pancreatic Ducts

Hutchings, D., Waters, K. M., Weiss, M. J., Wolfgang, C. L., Makary, M. A., He, J. P., Cameron, J. L., Wood, L. D., & Hruban, R. H. (2018) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001148 · Cited by 47

Identification and Analysis of Precursors to Invasive Pancreatic Cancer

Matthaei, H., Molin, M. D., & Maitra, A. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-287-2_1 · Cited by 47

Universal Antibody Conjugation to Nanoparticles Using the Fcγ Receptor I (FcγRI): Quantitative Profiling Of Membrane Biomarkers

Kim, C., Galloway, J. F., Lee, K. H., & Searson, P. C. (2014) · Bioconjugate Chemistry · doi:10.1021/bc5003778 · Cited by 46

miR-133a Functions as a Tumor Suppressor and Directly Targets FSCN1 in Pancreatic Cancer

Qin, Y., Dang, X., Li, W., & Qing-yong, M. (2014) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504014x14024160459122 · Cited by 46

Pancreatic intraepithelial neoplasia – can we detect early pancreatic cancer?

Haugk, B. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03610.x · Cited by 46

Fascin expression in 90 patients with glioblastoma multiforme

Roma, A. A., & Prayson, R. A. (2005) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2005.07.005 · Cited by 46

Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma

Schäfer, C., Seeliger, H., Bader, D. C., Assmann, G., Buchner, D., Guo, Y., Ziesch, A., Palagyi, A., Ochs, S., Laubender, R. P., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01473.x · Cited by 45

Overexpression of G1-S Cyclins and Cyclin-Dependent Kinases during Multistage Human Pancreatic Duct Cell Carcinogenesis

Al-Aynati, M. M., Radulovich, N., Ho, J., & Tsao, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0524 · Cited by 45

High‐grade Pan IN presenting with localised stricture of the main pancreatic duct: A clinicopathological and molecular study of 10 cases suggests a clue for the early detection of pancreatic cancer

Yokode, M., Akita, M., Fujikura, K., Kim, M., Morinaga, Y., Yoshikawa, S., Terada, T., Matsukiyo, H., Tajiri, T., Abe‐Suzuki, S., et al. (2018) · Histopathology · doi:10.1111/his.13629 · Cited by 44

Fascin is involved in tumor necrosis factor-α-dependent production of MMP9 in cholangiocarcinoma

Onodera, M., Zen, Y., Harada, K., Sato, Y., Ikeda, H., Itatsu, K., Sato, H., Ohta, T., Asaka, M., & Nakanuma, Y. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.89 · Cited by 44

Expression of a Fibroblast Growth Factor–Binding Protein during the Development of Adenocarcinoma of the Pancreas and Colon

Tassi, E., Henke, R. T., Bowden, E. T., Swift, M. R., Kodack, D. P., Kuo, A. H., Maitra, A., & Wellstein, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2926 · Cited by 44

Tissue microarrays: applications in genomic research

Watanabe, A. T., Cornelison, R., & Hostetter, G. H. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.2.171 · Cited by 44

Restoration of Smad4 in BxPC3 Pancreatic Cancer Cells Attenuates Proliferation without Altering Angiogenesis

Yasutome, M., Gunn, J. R., & Korc, M. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-2891-x · Cited by 44

Pre-Operative Imaging and Pathological Diagnosis of Localized High-Grade Pancreatic Intra-Epithelial Neoplasia without Invasive Carcinoma

Sagami, R., Yamao, K., Nakahodo, J., Minami, R., Tsurusaki, M., Murakami, K., & Amano, Y. (2021) · Cancers · doi:10.3390/cancers13050945 · Cited by 45

Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: A position paper from the Italian Registry

Chiaro, M. D., Zerbi, A., Capurso, G., Zamboni, G., Maisonneuve, P., Presciuttini, S., Arcidiacono, P. G., Calculli, L., & Falconi, M. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.04.016 · Cited by 43

Pathology Analysis Reveals That Dysplastic Pancreatic Ductal Lesions Are Frequent in Patients With Hereditary Pancreatitis

Rebours, V., Lévy, P., Mosnier, J., Scoazec, J., Soubeyrand, M., Fléjou, J., Turlin, B., Hammel, P. R., Ruszniewski, P. B., Bédossa, P., et al. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.09.009 · Cited by 43

The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma

Zhu, Y., Zhang, J., Zhu, R., Zhu, Y., Liang, W., Gao, W., Yu, J., Xu, Z., & Miao, Y. (2010) · Medical Oncology · doi:10.1007/s12032-010-9683-0 · Cited by 42

Fascin1 in carcinomas: Its regulation and prognostic value

Ma, Y., & Machesky, L. M. (2014) · International Journal of Cancer · doi:10.1002/ijc.29260 · Cited by 41

Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots

Lee, K. H., Galloway, J. F., Park, J., Dvoracek, C. M., Dallas, M. R., Konstantopoulos, K., Maitra, A., & Searson, P. C. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.01.005 · Cited by 41

New Era of Endoscopic Ultrasound-Guided Tissue Acquisition: Next-Generation Sequencing by Endoscopic Ultrasound-Guided Sampling for Pancreatic Cancer

Imaoka, H., Sasaki, M., Hashimoto, Y., Watanabe, K., & Ikeda, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081173 · Cited by 42

Pancreatic cancer: From molecular signature to target therapy

Longo, R., Cacciamani, F., Naso, G., & Gasparini, G. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.03.003 · Cited by 40

Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia

Koorstra, J.-B. M., Hong, S., Shi, C., Meeker, A. K., Ryu, J. K., Offerhaus, G. J. A., Goggins, M., Hruban, R. H., & Maitra, A. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.114 · Cited by 39

Expression of Kallikrein-Related Peptidase 7 Predicts Poor Prognosis in Patients with Unresectable Pancreatic Ductal Adenocarcinoma

Iakovlev, V. V., Siegel, E. R., Tsao, M., & Haun, R. S. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1079 · Cited by 39

The Prevalence of Pancreatic Intraepithelial Neoplasia in Pancreata With Uncommon Types of Primary Neoplasms

Stelow, E. B., Adams, R. B., & Moskaluk, C. A. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000180440.41280.a5 · Cited by 38

Pathology, genetics and precursors of human and experimental pancreatic neoplasms: An update

Esposito, I., Segler, A., Steiger, K., & Klöppel, G. (2015) · Pancreatology · doi:10.1016/j.pan.2015.08.007 · Cited by 39

Multivariate analysis of immunohistochemical evaluation of protein expression in pancreatic ductal adenocarcinoma reveals prognostic significance for persistent Smad4 expression only

Ottenhof, N. A., Morsink, F. H. M., ten Kate, F. J. W., Noorden, C. J. F. V., & Offerhaus, G. J. A. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0072-x · Cited by 38

Serial Analysis of Gene Expression Identifies Connective Tissue Growth Factor Expression as a Prognostic Biomarker in Gallbladder Cancer

Alvarez, H., Corvalán, A. H., Roa, J. C., Argani, P., Murillo, F., Edwards, J. B., Beaty, R. M., Feldmann, G., Hong, S., Mullendore, M. E., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1991 · Cited by 38

miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2

Dey, S., Kwon, J. J., Liu, S., Hodge, G. A., Taleb, S., Zimmers, T. A., Wan, J., & Kota, J. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0594 · Cited by 37

Molecular Biology of Pancreatic Ductal Adenocarcinoma Progression

Rhim, A. D., & Stanger, B. Z. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385233-5.00002-7 · Cited by 39

Proteome-based biomarkers in pancreatic cancer

Sun, C. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i44.4845 · Cited by 37

Cell Lineage Infidelity in PDAC Progression and Therapy Resistance

Malinova, A., Veghini, L., Real, F. X., & Corbo, V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.795251 · Cited by 39

Cytokeratin 20 expression identifies a subtype of pancreatic adenocarcinoma with decreased overall survival

Matros, E., Bailey, G., Clancy, T. E., Zinner, M. J., Ashley, S. W., Whang, E. E., & Redston, M. S. (2005) · Cancer · doi:10.1002/cncr.21609 · Cited by 36

Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice

Osvaldt, A. B., Wendt, L. R. R., Bersch, V. P., Backes, A. N., Schumacher, R. D. C. A., Edelweiss, M. I. A., & Rohde, L. (2006) · Surgery · doi:10.1016/j.surg.2006.02.012 · Cited by 35

Pancreatic cancer and associated exosomes

Zhao, C., Gao, F., Weng, S., & Liu, Q. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170258 · Cited by 34

Chronic Pancreatitis and Pancreatic Cancer: Prediction and Mechanism

Shimosegawa, T., Kume, K., & Satoh, K. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.07.042 · Cited by 34

The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: Insights for clinicians

Klöppel, G., & Lüttges, J. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0037-y · Cited by 34

Structural Analysis of the Cancer-specific Promoter in Mesothelin and in Other Genes Overexpressed in Cancers

Ren, Y. R., Patel, K. G., Paun, B. C., & Kern, S. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193458 · Cited by 33

Dendritic cells adenovirally-transduced with full-length mesothelin cDNA elicit mesothelin-specific cytotoxicity against pancreatic cancer cell lines in vitro

Miyazawa, M., Iwahashi, M., Ojima, T., Katsuda, M., Nakamura, M., Nakamori, M., Ueda, K., Naka, T., Hayata, K., Iida, T., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.013 · Cited by 32

MUC1 regulates cyclin D1 gene expression through p120 catenin and β-catenin

Liu, X., Caffrey, T. C., Steele, M. M., Mohr, A. M., Singh, P. K., Radhakrishnan, P., Kelly, D. L., Wen, Y., & Hollingsworth, M. A. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.19 · Cited by 33

Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review

Koyande, N. P., Srivastava, R., Padmakumar, A., & Rengan, A. K. (2022) · Vaccines · doi:10.3390/vaccines10101727 · Cited by 32

Fascin Determination in Urothelial Carcinomas of the Urinary Bladder: A Marker of Invasiveness

Karasavvidou, F., Barbanis, S., Pappa, D., Moutzouris, G., Tzortzis, V., Melekos, M. D., & Koukoulis, G. Κ. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/132.12.1912 · Cited by 31

Cancer Immunoprevention: Current Status and Future Directions

Keshavarz‐Fathi, M., & Rezaei, N. (2021) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-021-00604-x · Cited by 31

S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives

Wu, Y., Zhou, Q., Guo, F., Chen, M., Tao, X., & Dong, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.711180 · Cited by 30

Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia

Opitz, F. V., Häberle, L., Daum, A., & Esposito, I. (2021) · Cancers · doi:10.3390/cancers13246188 · Cited by 35

Reporting precursors to invasive pancreatic cancer: pancreatic intraepithelial neoplasia, intraductal neoplasms and mucinous cystic neoplasm

de Wilde, R. F., Hruban, R. H., Maitra, A., & Offerhaus, G. J. A. (2011) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2011.10.012 · Cited by 29

Does the Expression of Fascin-1 and Tumor Subclassification Help to Assess the Risk of Recurrence and Progression in T1 Urothelial Urinary Bladder Carcinoma?

Soukup, V., Babjuk, M., Duskova, J., Pešl, M., Szakáczová, M., Zámečník, L., & Dvořáček, J. (2008) · Urologia Internationalis · doi:10.1159/000132700 · Cited by 29

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma

Rebelo, R., Polónia, B. R. G., Santos, L. L., Vasconcelos, M. H., & Xavier, C. P. R. (2021) · Pharmaceuticals · doi:10.3390/ph14030280 · Cited by 30

K‐Ras‐Driven Pancreatic Cancer Mouse Model for Anticancer Inhibitor Analyses

Cook, N., Olive, K. P., Frese, K. K., & Tuveson, D. A. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)00406-5 · Cited by 28

Histological and immunohistological findings in biliary intraepithelial neoplasia arising from a background of chronic biliary disease compared with liver cirrhosis of non‐biliary aetiology

Aishima, S., Iguchi, T., Fujita, N., Taketomi, A., Maehara, Y., Tsuneyoshi, M., & Oda, Y. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.04011.x · Cited by 28

Pancreatic Intraepithelial Neoplasia

Cornish, T. C., & Hruban, R. H. (2011) · Surgical pathology clinics · doi:10.1016/j.path.2011.03.005 · Cited by 28

Staining for p53 and Ki-67 increases the sensitivity of EUS-FNA to detect pancreatic malignancy

Jahng, A. W. (2010) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v2.i11.362 · Cited by 27

Smad4 Loss Synergizes with TGFα Overexpression in Promoting Pancreatic Metaplasia, PanIN Development, and Fibrosis

García‐Carracedo, D., Yu, C.-C., Akhavan, N., Fine, S. A., Schönleben, F., Maehara, N., Karg, D. C., Xie, C., Qiu, W., Fine, R. L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120851 · Cited by 27

Gene expression profile comparison between colorectal cancer and adjacent normal tissues

Yang, Q., Feng, M., Ma, X., Li, H., & Xie, W. (2017) · Oncology Letters · doi:10.3892/ol.2017.6915 · Cited by 27

Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy

Liao, X., Han, C., Wang, X., Huang, K., Yu, T., Yang, C., Huang, R., Liu, Z., Han, Q., & Peng, T. (2018) · Cancer Management and Research · doi:10.2147/cmar.s171293 · Cited by 27

Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53

Calheiros, J., Corbo, V., & Saraiva, L. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188914 · Cited by 26

Fascin promotes the motility and invasiveness of pancreatic cancer cells

Xu, Y. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i40.4470 · Cited by 26

Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells

Bakke, J., Wright, W. C., Zamora, A. E., Oladimeji, P. O., Crawford, J. C., Brewer, C., Autry, R. J., Evans, W. E., Thomas, P. G., & Chen, T. (2019) · BMC Cancer · doi:10.1186/s12885-019-5455-1 · Cited by 26

Knockdown of fascin1 expression suppresses the proliferation and metastasis of gastric cancer cells

Fu, H., Wen, J., Hu, Z., Luo, G., & Ren, H. (2009) · Pathology · doi:10.3109/00313020903273100 · Cited by 25

Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer

van Roey, R., Brabletz, T., Stemmler, M. P., & Armstark, I. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.753456 · Cited by 26

Biology of Mesothelin and Clinical Implications: A Review of Existing Literature

Hagerty, B. L., & Takabe, K. (2023) · World Journal of Oncology · doi:10.14740/wjon1655 · Cited by 25

Absence of Pancreatic Intraepithelial Neoplasia Predicts Poor Survival After Resection of Pancreatic Cancer

Hassid, B. G., Lucas, A. L., Salomao, M. A., Weng, C., Liu, F., Khanna, L. G., Kumar, S., Hwang, C., Chabot, J. A., & Frucht, H. (2014) · Pancreas · doi:10.1097/mpa.0000000000000161 · Cited by 25

Limitations in Improving Detection of Pancreatic Adenocarcinoma

Zerón, H. M., Flores, J. R. G., & Romero, M. L. (2009) · Future Oncology · doi:10.2217/fon.09.32 · Cited by 25

Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma

Wang, C., Sun, Y., Wu, H., Yu, S., Zhang, L., Meng, Y., Liu, M., Yang, H., Liu, P., Mao, X., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3690-x · Cited by 24

The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review

Nichetti, F., Marra, A., Corti, F., Guidi, A., Raimondi, A., Prinzi, N., de Braud, F., & Pusceddu, S. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0567-0 · Cited by 23

Mouse models of Kras activation in gastric cancer

Won, Y., & Choi, E.-Y. K. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00882-1 · Cited by 23

Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies

Arakelyan, J., Zohrabyan, D., & Philip, P. A. (2020) · Cancer · doi:10.1002/cncr.33354 · Cited by 23

Evaluating Pancreatic and Biliary Neoplasms with Small Biopsy-Based Next Generation Sequencing (NGS): Doing More with Less

Nikas, I. P., Mountzios, G., Sydney, G. I., Ioakim, K. J., Won, J., & Papageorgis, P. (2022) · Cancers · doi:10.3390/cancers14020397 · Cited by 22

Loss of HNF6 expression correlates with human pancreatic cancer progression

Pekala, K. R., Ma, X., Kropp, P. A., Petersen, C. P., Hudgens, C. W., Chung, C. H., Shi, C., Merchant, N. B., Maitra, A., Means, A. L., et al. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.47 · Cited by 22

Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice: effects of alcohol and caffeine

Wendt, L. R. R., Osvaldt, A. B., Bersch, V. P., Schumacher, R. D. C. A., Edelweiss, M. I. A., & Rohde, L. (2007) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-86502007000300008 · Cited by 22

Genomic Landscapes of Pancreatic Neoplasia

Wood, L. D., & Hruban, R. H. (2015) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2014.12.26 · Cited by 22

Emerging Role of Fascin-1 in the Pathogenesis, Diagnosis, and Treatment of the Gastrointestinal Cancers

Ristić, B., Kopel, J. J., Sherazi, S. A. A., Gupta, S., Sachdeva, S., Bansal, P., Ali, A. B., Perisetti, A., & Goyal, H. (2021) · Cancers · doi:10.3390/cancers13112536 · Cited by 23

Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions

Buchholz, M., Braun, M., Heidenblut, A., Kestler, H. A., Klöppel, G., Schmiegel, W., Hahn, S. A., Lüttges, J., Gress, T. M., & Krebshilfe, F. T. G. P. C. N. O. T. D. (2005) · Oncogene · doi:10.1038/sj.onc.1208804 · Cited by 190

Pancreatic intra-epithelial neoplasia: current clinicopathological and molecular considerations

Andea, A. A., Baştürk, O., & Adsay, V. N. (2005) · Current Diagnostic Pathology · doi:10.1016/j.cdip.2004.11.008 · Cited by 2

MUC4 Expression Increases Progressively in Pancreatic Intraepithelial Neoplasia

Swartz, M. J., Batra, S. K., Varshney, G. C., Hollingsworth, M. A., Yeo, C. J., Cameron, J. L., Wilentz, R. E., Hruban, R. H., & Argani, P. (2002) · American Journal of Clinical Pathology · doi:10.1309/7y7n-m1wm-r0yk-m2va · Cited by 238

Update on pancreatic intraepithelial neoplasia.

Hruban, R. H., Maitra, A., & Goggins, M. (2008) · PubMed Central · Cited by 245

Molecular genetics of pancreatic intraepithelial neoplasia

Feldmann, G., Beaty, R., Hruban, R. H., & Maitra, A. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1166-5 · Cited by 269